Literature DB >> 3192855

The effects of acutely increased ventricular cavity pressure on intrinsic myocardial connective tissue.

S M Factor1, M Flomenbaum, M J Zhao, C Eng, T F Robinson.   

Abstract

Studies of normal hearts have revealed a variety of intrinsic connective tissue structures that surround and interconnect myocytes and ventricular mural layers. Among these structures, springlike coiled perimysial fibers, arrayed parallel to myocytes in the interstitial space, have been described in papillary muscle and ventricle. To evaluate the role of the coiled perimysial fibers under perturbed conditions, rat ventricles were filled with barium-gelatin under different pressures and fixed, and then the myocardium was impregnated with silver to visualize the connective tissue. Ventricles were filled at 30, 70 and 100 to 120 mm Hg. The coiled perimysial fibers were studied for their orientation, stretch, integrity and relation to sarcomere length. The coils were noted to embed within the fibrous anulus and to knot into an umbilical-like mass at the apex, thus anchoring them at both ends of the ventricle. They underwent focal straightening even at 30 mm Hg, with generalized straightening and disruption at the highest pressure; changes were most pronounced in the midventricle. Sarcomeres were maintained below 2.2 micron at 30 and 70 mm Hg of cavity pressure in regions of coiled perimysial fiber stretch; only with fiber disruption at 100 to 120 mm Hg were sarcomeres significantly lengthened. Other findings included connective tissue disruption between ventricular wall layers that allowed slippage of myocytes and mural thinning. These observations suggest that coiled perimysial fibers may act as a buffer to protect myocytes from damage under the effects of high cavity pressure.

Entities:  

Mesh:

Year:  1988        PMID: 3192855     DOI: 10.1016/s0735-1097(88)80029-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Right ventricular pressure and dilation during pressure overload determine dysfunction after pressure overload.

Authors:  C Greyson; Y Xu; L Lu; G G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-05       Impact factor: 4.733

Review 2.  Echocardiographic assessment of left ventricular function.

Authors:  Mario J Garcia
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

3.  Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs.

Authors:  F D Pagani; L S Baker; C Hsi; M Knox; M P Fink; M S Visner
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

4.  Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures.

Authors:  Bodh I Jugdutt; Halliday Idikio; Richard R E Uwiera
Journal:  Mol Cell Biochem       Date:  2007-05-09       Impact factor: 3.396

5.  Structural arrangement of the extracellular matrix network during myocardial development in the chick embryo heart.

Authors:  D Sanchez-Quintana; V Garcia-Martinez; D Macias; J M Hurle
Journal:  Anat Embryol (Berl)       Date:  1991

6.  Left ventricular perimysial collagen fibers uncoil rather than stretch during diastolic filling.

Authors:  D A MacKenna; J H Omens; J W Covell
Journal:  Basic Res Cardiol       Date:  1996 Mar-Apr       Impact factor: 17.165

Review 7.  Cardiac rehabilitation in heart failure with severely reduced ejection fraction: effects on mortality.

Authors:  Negin Sadat Hosseini Mohammadi; Mohammad Hasan Shaki Katouli; Farzad Masoudkabir; Alipasha Meysamie; Kiarash Tavakoli; Ali Vasheghani-Farahani
Journal:  Heart Fail Rev       Date:  2022-05-21       Impact factor: 4.214

8.  Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression.

Authors:  M Crabos; M Roth; A W Hahn; P Erne
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.